VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-7.72 Cr | ₹-4.24 Cr | ₹-1.99 Cr | ₹-0.90 Cr | ₹-0.44 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VIMTA LABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2024 | ₹-7.72 Cr |
| Mar2023 | ₹-4.24 Cr |
| Mar2022 | ₹-1.99 Cr |
| Mar2021 | ₹-0.90 Cr |
| Mar2020 | ₹-0.44 Cr |
How is Deferred Tax Assets / Liabilities of VIMTA LABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹-7.72 Cr | Negative | |
| Mar2023 | ₹-4.24 Cr | Negative | |
| Mar2022 | ₹-1.99 Cr | Negative | |
| Mar2021 | ₹-0.90 Cr | Negative | |
| Mar2020 | ₹-0.44 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,078.1 Cr | -4.7% | -8.6% | 0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,217.0 Cr | 0.4% | 5.6% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,047.0 Cr | -0.5% | 3.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,872.0 Cr | 4.5% | 10% | 41.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,454.0 Cr | 1.5% | 4.8% | 9.1% | Stock Analytics | |
| CIPLA | ₹107,136.0 Cr | -1.7% | 1% | -10.5% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -4.7% |
-8.6% |
0.1% |
| SENSEX | -1.5% |
0.8% |
8.2% |
You may also like the below Video Courses